GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LabTurbo Biotech Corp (ROCO:7725) » Definitions » COGS-to-Revenue

LabTurbo Biotech (ROCO:7725) COGS-to-Revenue : 0.97 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LabTurbo Biotech COGS-to-Revenue?

LabTurbo Biotech's Cost of Goods Sold for the six months ended in Dec. 2024 was NT$30.89 Mil. Its Revenue for the six months ended in Dec. 2024 was NT$31.91 Mil.

LabTurbo Biotech's COGS to Revenue for the six months ended in Dec. 2024 was 0.97.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. LabTurbo Biotech's Gross Margin % for the six months ended in Dec. 2024 was 3.20%.


LabTurbo Biotech COGS-to-Revenue Historical Data

The historical data trend for LabTurbo Biotech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LabTurbo Biotech COGS-to-Revenue Chart

LabTurbo Biotech Annual Data
Trend Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
0.30 0.26 0.83 0.77

LabTurbo Biotech Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial 0.38 0.77 1.33 0.61 0.97

LabTurbo Biotech COGS-to-Revenue Calculation

LabTurbo Biotech's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=55.953 / 72.975
=0.77

LabTurbo Biotech's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=30.885 / 31.907
=0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LabTurbo Biotech  (ROCO:7725) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

LabTurbo Biotech's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 30.885 / 31.907
=3.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


LabTurbo Biotech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of LabTurbo Biotech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LabTurbo Biotech Business Description

Traded in Other Exchanges
N/A
Address
3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.

LabTurbo Biotech Headlines

No Headlines